Explore
Validate
LearnABIN358375
antibody from antibodies-online
Targeting: MAPK14
CSBP1, CSBP2, CSPB1, Mxi2, p38, PRKM14, PRKM15
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN358375 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Mitogen-Activated Protein Kinase 14 (MAPK14) (pTyr322) antibody
- Antibody type
- Polyclonal
- Antigen
- This antibody is generated from rabbits immunized with a KLH conjugated synthetic phosphopeptide corresponding to amino acid residues surrounding Tyr322 of human MAPK14.
- Description
- Protein A Affinity Chromatography. Then, the antibody fraction is peptide affinity purified in a 2-step procedure with peptides. The antibody is eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS.
- Reactivity
- Human
- Host
- Rabbit
- Epitope
- pTyr322
- Vial size
- 0.4 mL
- Concentration
- 0.25 mg/mL
- Storage
- Store the antibody undiluted at 2-8°C for one month or (in aliquots) at-20°C for longer.
- Handling
- Avoid repeated freezing and thawing.
Submitted references Comparative studies of a new subfamily of human Ste20-like kinases: homodimerization, subcellular localization, and selective activation of MKK3 and p38.
P38 MAP kinase is activated at early stages in Alzheimer's disease brain.
p38 Mitogen-activated protein kinase stabilizes mRNAs that contain cyclooxygenase-2 and tumor necrosis factor AU-rich elements by inhibiting deadenylation.
Feedback control of the protein kinase TAK1 by SAPK2a/p38alpha.
p38 Mitogen-activated protein kinase-dependent and -independent signaling of mRNA stability of AU-rich element-containing transcripts.
Yustein JT, Xia L, Kahlenburg JM, Robinson D, Templeton D, Kung HJ
Oncogene 2003 Sep 18;22(40):6129-41
Oncogene 2003 Sep 18;22(40):6129-41
P38 MAP kinase is activated at early stages in Alzheimer's disease brain.
Sun A, Liu M, Nguyen XV, Bing G
Experimental neurology 2003 Oct;183(2):394-405
Experimental neurology 2003 Oct;183(2):394-405
p38 Mitogen-activated protein kinase stabilizes mRNAs that contain cyclooxygenase-2 and tumor necrosis factor AU-rich elements by inhibiting deadenylation.
Dean JL, Sarsfield SJ, Tsounakou E, Saklatvala J
The Journal of biological chemistry 2003 Oct 10;278(41):39470-6
The Journal of biological chemistry 2003 Oct 10;278(41):39470-6
Feedback control of the protein kinase TAK1 by SAPK2a/p38alpha.
Cheung PC, Campbell DG, Nebreda AR, Cohen P
The EMBO journal 2003 Nov 3;22(21):5793-805
The EMBO journal 2003 Nov 3;22(21):5793-805
p38 Mitogen-activated protein kinase-dependent and -independent signaling of mRNA stability of AU-rich element-containing transcripts.
Frevel MA, Bakheet T, Silva AM, Hissong JG, Khabar KS, Williams BR
Molecular and cellular biology 2003 Jan;23(2):425-36
Molecular and cellular biology 2003 Jan;23(2):425-36
No comments: Submit comment
No validations: Submit validation data